Trial Profile
Subcutaneous Injection of Exendin (9-39) in Subjects With Hyperinsulinemic Hypoglycemia Post-Bariatric Surgery
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Avexitide (Primary)
- Indications Hyperinsulinaemia; Hypoglycaemia
- Focus Pharmacokinetics
- 21 Dec 2016 New trial record